These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156 [TBL] [Abstract][Full Text] [Related]
4. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187 [TBL] [Abstract][Full Text] [Related]
9. Human umbilical cord cells: a new cell source for cardiovascular tissue engineering. Kadner A; Hoerstrup SP; Tracy J; Breymann C; Maurus CF; Melnitchouk S; Kadner G; Zund G; Turina M Ann Thorac Surg; 2002 Oct; 74(4):S1422-8. PubMed ID: 12400830 [TBL] [Abstract][Full Text] [Related]
10. Porcine Umbilical Cord Perivascular Cells for Preclinical Testing of Tissue-Engineered Heart Valves. Latifi N; Lecce M; Simmons CA Tissue Eng Part C Methods; 2021 Jan; 27(1):35-46. PubMed ID: 33349127 [TBL] [Abstract][Full Text] [Related]
12. Living autologous heart valves engineered from human prenatally harvested progenitors. Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561 [TBL] [Abstract][Full Text] [Related]
13. Tissue engineering for neurodegenerative diseases using human amniotic membrane and umbilical cord. Sanluis-Verdes A; Sanluis-Verdes N; Manso-Revilla MJ; Castro-Castro AM; Pombo-Otero J; Fraga-Mariño M; Sanchez-Ibañez J; Doménech N; Rendal-Vázquez ME Cell Tissue Bank; 2017 Mar; 18(1):1-15. PubMed ID: 27830445 [TBL] [Abstract][Full Text] [Related]
14. Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors. Schmidt D; Asmis LM; Odermatt B; Kelm J; Breymann C; Gössi M; Genoni M; Zund G; Hoerstrup SP Ann Thorac Surg; 2006 Oct; 82(4):1465-71; discussion 1471. PubMed ID: 16996955 [TBL] [Abstract][Full Text] [Related]
15. Ectopic vascularized bone formation by human umbilical cord-derived mesenchymal stromal cells expressing bone morphogenetic factor-2 and endothelial cells. Yang SJ; Son JK; Hong SJ; Lee NE; Shin DY; Park SH; An SB; Sung YC; Park JB; Yang HM; Kim SJ Biochem Biophys Res Commun; 2018 Sep; 504(1):302-308. PubMed ID: 30190122 [TBL] [Abstract][Full Text] [Related]
16. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? El Omar R; Beroud J; Stoltz JF; Menu P; Velot E; Decot V Tissue Eng Part B Rev; 2014 Oct; 20(5):523-44. PubMed ID: 24552279 [TBL] [Abstract][Full Text] [Related]
17. Potential cell sources for tissue engineering of heart valves in comparison with human pulmonary valve cells. Schaefermeier PK; Cabeza N; Besser JC; Lohse P; Daebritz SH; Schmitz C; Reichart B; Sodian R ASAIO J; 2009; 55(1):86-92. PubMed ID: 19092668 [TBL] [Abstract][Full Text] [Related]
18. Umbilical cord as human cell source for mitral valve tissue engineering - venous vs. arterial cells. Malischewski A; Moreira R; Hurtado L; Gesché V; Schmitz-Rode T; Jockenhoevel S; Mela P Biomed Tech (Berl); 2017 Oct; 62(5):457-466. PubMed ID: 28453437 [TBL] [Abstract][Full Text] [Related]
19. Use of human umbilical cord blood-derived progenitor cells for tissue-engineered heart valves. Sodian R; Schaefermeier P; Abegg-Zips S; Kuebler WM; Shakibaei M; Daebritz S; Ziegelmueller J; Schmitz C; Reichart B Ann Thorac Surg; 2010 Mar; 89(3):819-28. PubMed ID: 20172137 [TBL] [Abstract][Full Text] [Related]